Quantitative (31)P HR-MAS MR spectroscopy for detection of response to PI3K/mTOR inhibition in breast cancer xenografts. - sprookjes - yvandenbroek - TriplyDB

Quantitative (31)P HR-MAS MR spectroscopy for detection of response to PI3K/mTOR inhibition in breast cancer xenografts.

Quantitative (31)P HR-MAS MR spectroscopy for detection of response to PI3K/mTOR inhibition in breast cancer xenografts.

http://www.wikidata.org/entity/Q42441848

about

Evaluation of Cancer Metabolomics Using ex vivo High Resolution Magic Angle Spinning (HRMAS) Magnetic Resonance Spectroscopy (MRS)Intratumoral Agreement of High-Resolution Magic Angle Spinning Magnetic Resonance Spectroscopic Profiles in the Metabolic Characterization of Breast Cancer.MR Studies of Glioblastoma Models Treated with Dual PI3K/mTOR Inhibitor and Temozolomide:Metabolic Changes Are Associated with Enhanced Survival.Effects of tyrosine kinase inhibitors and CXCR4 antagonist on tumor growth and angiogenesis in rat glioma model: MRI and protein analysis study.Plasma Metabolomic Changes following PI3K Inhibition as Pharmacodynamic Biomarkers: Preclinical Discovery to Phase I Trial Evaluation.Pitfalls to be considered on the metabolomic analysis of biological samples by HR-MAS.Metabolomic changes during cellular transformation monitored by metabolite-metabolite correlation analysis and correlated with gene expression.Probing the PI3K/Akt/mTor pathway using (31)P-NMR spectroscopy: routes to glycogen synthase kinase 3.

P2860

Q26751944-B3E2BD1A-8DE4-49C4-8011-968A566134E4 Q36822535-C7667637-6D64-48A0-A03C-7ED1648C0FA3 Q36918102-81248AE0-3598-4B10-8E9A-966C8288F82E Q37474359-79189FF8-46CA-49D4-9653-141AA99C056C Q37660266-3E2A264F-A1A4-4EEB-B369-AA54B44DB8C9 Q40071956-C4F4232D-2315-45EB-A174-22C20E3581D0 Q40403745-12558F1C-D6AF-444C-9C51-0B638EDBD13C Q42120404-CC3A5C01-9B7E-47F0-B1CE-3CBC52E7DB12

P2860

Quantitative (31)P HR-MAS MR spectroscopy for detection of response to PI3K/mTOR inhibition in breast cancer xenografts.

http://www.wikidata.org/entity/Q42441848

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Quantitative (31)P HR-MAS MR s ...... n in breast cancer xenografts.

@en

type

label

Quantitative (31)P HR-MAS MR s ...... n in breast cancer xenografts.

@en

prefLabel

Quantitative (31)P HR-MAS MR s ...... n in breast cancer xenografts.

@en

P1433

Q42441848-88E87B17-AB75-4325-9060-1DC2E7FE98C2

P1476

Q42441848-49D2DF46-235F-4BD0-AD82-C78FC2F41013

P2093

Q42441848-99925298-DDAF-40CD-9AD1-0A711B0FA41B

Q42441848-CD95318C-1B1A-415A-9DFC-C8C9231E6D7D

Q42441848-DC1BCB91-11AB-4B48-8D0B-F9D644016B0F

P2860

Q42441848-0EC28142-C00D-4878-8C93-515ACE8271C2

Q42441848-15E0CC70-DACE-472C-829A-C869ED18A4C2

Q42441848-163481A4-0566-419C-AC0C-5759CF198583

Q42441848-1AF9543F-76A7-4E97-A250-DD84FA13EFF7

Q42441848-2826DF7F-D1A5-455B-BFBE-F0AEF7DCBBFD

Q42441848-38BFE8F0-D697-4894-AF89-2C512C371CD8

Q42441848-4068CCBB-BDFC-4E56-8B6A-4D4924698116

Q42441848-432512B3-5120-448A-A4A0-001740FB89A4

Q42441848-4F138B6A-635A-4FE1-8894-C4D06702621C

Q42441848-58DCCCB2-A116-4CA8-9F7A-F060B0D8FEEF

P304

Q42441848-557DA607-19DF-4B31-89E7-3C7CCC43C751

P31

Q42441848-E265020D-763B-4AD0-B385-4AFD8160B224

P356

Q42441848-14C0E78A-3440-4040-9D65-6F363CE79EE2

P433

Q42441848-4B35B610-79DE-4E53-94CB-FC92BD4FE08A

P478

Q42441848-F9D00216-5D0D-433F-AE78-C018171D2055

P50

Q42441848-0D758779-A107-4D03-AACD-CA4821711676

Q42441848-557818A1-23FC-4EDF-9047-B8E76DC68356

Q42441848-AC0FA5DA-44F5-4BC5-A23F-756ABB5EDE89

P577

Q42441848-51D2FC91-6064-4443-B3C2-13C6997A5A49

P698

Q42441848-C48ACAD5-B84B-4F24-8FD6-58107E830761

P921

Q42441848-FEE96D41-6252-4670-A70F-31E22FE03836

P356

P1433

Magnetic Resonance in Medicine

P1476

Quantitative (31)P HR-MAS MR s ...... n in breast cancer xenografts.

@en

P2093

Morteza Esmaeili

http://www.w3.org/2001/XMLSchema#string

Olav Engebråten

http://www.w3.org/2001/XMLSchema#string

Siver A Moestue

http://www.w3.org/2001/XMLSchema#string

P2860

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Molecular portraits of human breast tumours

The emerging mechanisms of isoform-specific PI3K signalling

Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity

Choline-releasing glycerophosphodiesterase EDI3 drives tumor cell migration and metastasis

Metabolite changes in HT-29 xenograft tumors following HIF-1alpha inhibition with PX-478 as studied by MR spectroscopy in vivo and ex vivo.

Tumour phospholipid metabolism.

Specific apoptosis induction by the dual PI3K/mTor inhibitor NVP-BEZ235 in HER2 amplified and PIK3CA mutant breast cancer cells

Distinct choline metabolic profiles are associated with differences in gene expression for basal-like and luminal-like breast cancer xenograft models

Activation of phosphatidylcholine cycle enzymes in human epithelial ovarian cancer cells.

P304

1973-1981

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MRM.24869

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

71

http://www.w3.org/2001/XMLSchema#string

P50

Ingrid Susann Gribbestad

Gunhild M. Mælandsmo

P577

2013-07-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23878023

http://www.w3.org/2001/XMLSchema#string

P921